Month: September 2022
What can you do to find Lung Cancer early?
Are there any screening tests for lung cancer? Yes, low dose CT chest (LDCT) scan can be performed to screen lung cancer. It may help…
Immunotherapy Durvalumab with chemotherapy improved survival in Biliary Tract Cancer
Durvalumab immunotherapy improved overall survival in biliary tract cancer patients when added to standard chemotherapy. September 2022, US FDA approved this combination treatment for biliary…
Multiple Myeloma – new treatment with biclonal antibodies (Teclistamab)
Teclistamab is a new antibody drug for multiple myeloma patients. It is classified as a bispecific antibodies. These antibodies are capable of binding to T-cells…
Immunotherapy and chemotherapy in Triple Negative Breast Cancer (TNBC) – New treatment before surgery
The addition of immunotherapy has shown improvement in distant recurrence. The results were discussed in Keynote-522 study. The study used pembrolizumab as the drug for…
Lung Cancer (non small cell lung cancer) new treatment approval by FDA for MET exon 14 skip mutation – Capmatinib (Tabrecta, Novartis Pharmaceuticals Corp.)
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-capmatinib-metastatic-non-small-cell-lung-cancer